May. 15, 2020
On April 30, China’s Jiujiang Shanshui Technology disclosed its IPO prospectus, with a plan to raise Yuan1.313 billion on ChiNext of the Shenzhen Stock Exchange, to be mainly used for the construction of the annual 61,000-ton chloropyridine and annual 15,000-ton 2-chloro-5 (chloromethyl) pyridine production facilities, including the establishment of an R&D building.
Shanshui Technology, founded in 2012, is headquartered in Pengze County, Jiujiang City, Jiangxi Province, being engaged in the R&D, production and sales of dyestuff intermediates, pesticides and pharmaceutical intermediates. Its dyestuff intermediates include 6-nitro, 5-nitro and orthanilic acid, while pesticide and pharmaceutical intermediates include the 2-chloropyridine series.
Since being founded, Shanshui Technology established an independent technical center, where 30% of the company’s profit is allocated yearly for technical research. At present, Shanshui Technology has been granted 22 national patents and two scientific and technological awards in Jiangxi Province for the naphthalene intermediate series and the pyridine product series.